Cargando…

Properties of odor identification testing in screening for early-stage Alzheimer’s disease

Odor identification (OI) is impaired in the early stages of Alzheimer’s disease (AD). However, data regarding the diagnostic properties of OI tests are lacking, preventing their clinical use. We aimed to explore OI and determine the accuracy of OI testing in screening for patients with early AD. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Audronyte, Egle, Pakulaite-Kazliene, Gyte, Sutnikiene, Vaiva, Kaubrys, Gintaras
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102162/ https://www.ncbi.nlm.nih.gov/pubmed/37055436 http://dx.doi.org/10.1038/s41598-023-32878-w

Ejemplares similares

Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer Disease
por: Audronyte, Egle, et al.
Publicado: (2023)

Odor Discrimination as a Marker of Early Alzheimer’s Disease
por: Audronyte, Egle, et al.
Publicado: (2023)

Olfactory memory in mild cognitive impairment and Alzheimer’s disease
por: Audronyte, Egle, et al.
Publicado: (2023)

Distinctive Effect of Donepezil Treatment on P300 and N200 Subcomponents of Auditory Event-Related Evoked Potentials in Alzheimer Disease Patients
por: Vaitkevičius, Arūnas, et al.
Publicado: (2015)

Specific Features of Executive Dysfunction in Alzheimer-Type Mild Dementia Based on Computerized Cambridge Neuropsychological Test Automated Battery (CANTAB) Test Results
por: Kuzmickienė, Jurgita, et al.
Publicado: (2016)

Cognitive Results of CANTAB Tests and Their Change Due to the First Dose of Donepezil May Predict Treatment Efficacy in Alzheimer Disease
por: Kuzmickienė, Jurgita, et al.
Publicado: (2015)

Selective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease
por: Kuzmickienė, Jurgita, et al.
Publicado: (2015)

Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests
por: Giedraitiene, Natasa, et al.
Publicado: (2019)

Perception of Fechner Illusory Colors in Alzheimer Disease Patients
por: Kaubrys, Gintaras, et al.
Publicado: (2016)

Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study
por: Giedraitiene, Natasa, et al.
Publicado: (2021)

Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke's Cognitive Examination-Revised (ACE-R)
por: Rotomskis, Augustinas, et al.
Publicado: (2015)

The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration
por: Giedraitienė, Nataša, et al.
Publicado: (2015)

Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis
por: Giedraitiene, Natasa, et al.
Publicado: (2018)

Heterogeneity of odorant identification impairment in patients with Alzheimer’s Disease
por: Umeda-Kameyama, Yumi, et al.
Publicado: (2017)

Development of Chinese odor identification test
por: Su, Baihan, et al.
Publicado: (2021)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
por: Motter, Jeffrey N., et al.
Publicado: (2021)

Detection of aquaporin‐4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania
por: Sakalauskaitė‐Juodeikienė, Eglė, et al.
Publicado: (2018)

Emotional and Phenomenological Properties of Odor-Evoked Autobiographical Memories in Alzheimer’s Disease
por: Glachet, Ophélie, et al.
Publicado: (2019)

Odor Mixtures in Identification Testing Using Sniffin’ Sticks: The SSomix Test
por: Liu, David Tianxiang, et al.
Publicado: (2020)

Effect of A/T/N imaging biomarkers on impaired odor identification in Alzheimer's disease
por: Baek, Min Seok, et al.
Publicado: (2020)

Odor familiarity and improvement of olfactory identification test in Chinese population
por: Zhang, Hao, et al.
Publicado: (2023)

The “Sniffin' Kids” Test - A 14-Item Odor Identification Test for Children
por: Schriever, Valentin A., et al.
Publicado: (2014)

Differences in Odor Identification in Early-Onset and Late-Onset Depression
por: Liu, Meiling, et al.
Publicado: (2022)

Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
por: Kizlaitienandedot, Rasa, et al.
Publicado: (2017)

Brain Structural Correlates of Odor Identification in Mild Cognitive Impairment and Alzheimer’s Disease Revealed by Magnetic Resonance Imaging and a Chinese Olfactory Identification Test
por: Wu, Xingqi, et al.
Publicado: (2019)

Development of the Lithuanian Version of Sniffin’ Sticks 12 Odor Identification Test
por: Čičelienė, Jolita, et al.
Publicado: (2018)

Evaluation of Culturally-Familiar Odorants for a Persian Smell Identification Test
por: Kamrava, Seyed Kamran, et al.
Publicado: (2018)

Dipyrazolo[1,5-a:4',3'-c]pyridines – a new heterocyclic system accessed via multicomponent reaction
por: Holzer, Wolfgang, et al.
Publicado: (2012)

The Structural Properties of Odorants Modulate Their Association to Human Odorant Binding Protein
por: Castro, Tarsila G., et al.
Publicado: (2021)

Perceptual odor qualities predict successful odor identification in old age
por: Lindroos, Robert, et al.
Publicado: (2022)

Novel In-Frame Deletion in HTRA1 Gene, Responsible for Stroke at a Young Age and Dementia—A Case Study
por: Grigaitė, Julija, et al.
Publicado: (2021)

The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer’s disease
por: Kjelvik, Grete, et al.
Publicado: (2014)

Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability
por: Giedraitiene, Natasa, et al.
Publicado: (2015)

Objective Assessment of Hyposmia in Alzheimer's Disease From Image and Behavior by Combining Pleasant Odor With Unpleasant Odor
por: Feng, Quanzhi, et al.
Publicado: (2021)

Positive relationship between odor identification and affective responses of negatively valenced odors
por: Martinec Nováková, Lenka, et al.
Publicado: (2015)

A Meta-Analysis of Odor Thresholds and Odor Identification in Autism Spectrum Disorders
por: Larsson, Maria, et al.
Publicado: (2017)

Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China
por: Huang, Si-Fei, et al.
Publicado: (2016)

Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease
por: Mahlknecht, Philipp, et al.
Publicado: (2016)

Hibernation Impairs Odor Discrimination – Implications for Alzheimer’s Disease
por: Bullmann, Torsten, et al.
Publicado: (2019)

Neuroprotection in early stages of Alzheimer’s disease is promoted by transthyretin angiogenic properties
por: Gião, Tiago, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bedu7dpvofjmklgh5m1f5ql05r